Bioactivity:

Atopaxar, a reversible PAR-1 thrombin receptor antagonist, interferes with platelet signaling. Atopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome.

CAS nr:

751475-53-3

Purity:

98%

Molecular Weight:

527,63

SMILES:

CCOc1c(OCC)c(F)c2C(=N)N(CC(=O)c3cc(c(OC)c(c3)N3CCOCC3)C(C)(C)C)Cc2c1

Formula:

C29H38FN3O5

Pathway:

GPCR/G Protein

Target:

Protease-activated Receptor